January 20, 2021
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today named DeChane Dorsey the new Executive Director of AdvaMed Accel, the division within AdvaMed dedicated to the needs of small and start-up medical technology manufacturers. DeChane was previously AdvaMed’s Vice President of Payment and Health Care Delivery Policy, a role she has held since 2006.
Scott Whitaker, President and CEO of AdvaMed, commented on DeChane’s new appointment, saying:
“DeChane is an exceptional and intelligent leader. She is thorough and thoughtful; she conducts herself with grace and grit; she provides valued counsel and is a great confidant. It’s her innovative spirit and can-do attitude that make DeChane the right choice to lead AdvaMed Accel at this important time in our history.
“DeChane has helped secure many policy wins in the coding and reimbursement landscape – on the physician fee schedule, hospital outpatient prospective payment system, and ambulatory surgery center payment system.
“But her work extends beyond the payment space. During a challenging year marked by racial unrest, DeChane led AdvaMed’s health equity work, which has been a tremendous accomplishment for our industry. Her leadership helped solidify AdvaMed as a solution-oriented thought leader in the health equity discussion.
“I know our small medtech companies – the lifeblood of the medtech industry – will flourish with her at the helm.”
Martha Shadan, President and CEO of Miach Orthopaedics and Chair of AdvaMed Accel, echoed Whitaker’s sentiments, saying:
“AdvaMed Accel operates on one founding principle: Small medical technology manufacturers have unique needs that require specialized attention within the AdvaMed network. These issues have never been more apparent – and that specialized attention has never been more important – than right now during the Covid-19 pandemic. We’re so pleased to have someone of DeChane’s caliber take leadership of Accel at this critical time.
She has the know-how and the experience our organization needs to be successful, but more than that, she has the passion and the dedication it takes to ensure that our success is sustained and significant.
I can’t wait to start working with DeChane, so, together, we can make sure today’s emerging medtech companies are able to deliver tomorrow’s medical miracles.”
DeChane confirmed her excitement and readiness to take on the top role at AdvaMed Accel, saying:
“Our AdvaMed Accel members are on the verge of some of the most promising medical breakthroughs – and they depend on AdvaMed Accel to help them take their ideas from inception to market.
“I’ve been working with AdvaMed Accel members for years on the payment side, making sure they understand the Medicare payment, coding, and coverage issues that can make or break their success. As Executive Director of AdvaMed Accel, I look forward to working with these companies in other areas as well – to help take their companies to new levels.
“I’m ready to do everything I can to make sure these companies’ voices are heard by policymakers, but more than that, to leverage their voices to create a better innovation ecosystem. Small business is anything but small, especially in the health care system.
As AdvaMed’s Vice President of Payment and Health Care Delivery Policy, DeChane provided analysis and guidance to association members on Medicare payment, coding, and coverage issues; and developed the association’s policy positions for improved payment and coding infrastructure. DeChane is also team lead on AdvaMed’s heath equity workstream, spearheading the creation and execution of AdvaMed’s Principles on Health Equity. DeChane will retain this responsibility in her new role with AdvaMed Accel.
Before joining AdvaMed, DeChane served as Director of Health Policy for the American Academy of Ophthalmology and as Senior Counsel in the Office of Counsel to the Inspector General within the U.S. Department of Health and Human Services. DeChane started her career as a Westwood Fellow at the Neighborhood Legal Services Program in Washington, D.C.
DeChane received a Bachelor of Arts in Political Science from Syracuse University and a Juris Doctor from Georgetown University Law Center.
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies.